Identification of the preemptive effect of visceral pai
- Conditions
- Diseases of the digestive system
- Registration Number
- KCT0003810
- Lead Sponsor
- Asan Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 70
1) Adults from 20 to 80 years
2) ASA physical status I and II
3) Patients who voluntarily agreed in writing to participate in the clinical trial
4) Patients planed to undergo laparoscopic cholecystectomy with regular schedule
1) side effects to local anesthetics or steroids
2) Those who are taboo of neuroprotection such as blood clotting disorder, infection, etc.
3) uncontrolled medical or psychological problem
4) patient does not agree to participate in the study
5) Patients with spinal or thoracic deformities
6) Patients who are pregnant or breastfeeding
7) Patients with pre-operative PTGBD or ENBD
8) Patients who underwent extensive resection during surgery and are expected to have visceral pain too high
9) Patients receiving single port laparoscopic cholecystectomy (including using a robot)
10) Patients with severe intraabdominal adhesion (parkland grade 3 or higher)
11) Patients with a history of intraoperative abdominal surgery
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the difference of postoperative opioid consumption between two groups during 24 hours postoperatively
- Secondary Outcome Measures
Name Time Method Postoperative pain intensity, location at 0, 1/2, 1, 2, 6, 9, 18, 24 hours after end of surgery;post operative Nausea, vomiting, dizziness, pruritus and hematoma at 0, 1/2, 1, 2, 6, 9, 18, 24 hours after end of surgery;paresthesia or hypoesthesia on block site